RT Journal Article SR Electronic T1 Pathophysiology of pulmonary function anomalies in COVID-19 survivors JF Breathe JO Breathe FD European Respiratory Society SP 210065 DO 10.1183/20734735.0065-2021 VO 17 IS 3 A1 Pierantonio Laveneziana A1 Lucile Sesé A1 Thomas Gille YR 2021 UL http://breathe.ersjournals.com/content/17/3/210065.abstract AB Coronavirus disease 2019 (COVID-19) is a disease caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-​2), and the predisposing and protecting factors have not been fully elucidated. COVID-19 primarily impacts the respiratory system, and can result in mild illness or serious disease leading to critical illness requiring admission to the intensive care unit due to respiratory failure. After hospital discharge, the more commonly described pulmonary function anomalies are alterations in diffusing capacity and the loss of lung volume. Reduction of inspiratory muscle contraction may also be underestimated. This article will focus on the pathophysiology of pulmonary function anomalies in COVID-19 survivors. We will discuss current advances and provide future directions and also present our perspective on this field.COVID-19 primarily impacts the respiratory system and can result in long-standing alterations in pulmonary function such as anomalies in diffusing capacity and the loss of lung volume https://bit.ly/3gKDo5e